Cargando…

De-escalation of P2Y12 Inhibitor Use After Percutaneous Coronary Intervention and Acute Coronary Syndromes

BACKGROUND: De-escalation from potent platelet P2Y12 inhibitors to clopidogrel is common. Despite having a clinical rationale, non-bleeding-related de-escalation when a lateral change between potent agents is an option may put patients at increased ischemic risk. We set out to define the scope of P2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barry, Quinton, Fu, Angel, Boudreau, Rene, Chow, Alyssa, Clifford, Cole, Simard, Trevor, Chong, Aun Yeong, Dick, Alexander, Froeschl, Michael, Glover, Christopher, Hibbert, Benjamin, Labinaz, Marino, Le May, Michel, Russo, Juan, So, Derek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531228/ https://www.ncbi.nlm.nih.gov/pubmed/34712935 http://dx.doi.org/10.1016/j.cjco.2021.04.010

Ejemplares similares

A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study
por: Hibbert, Benjamin, et al.
Publicado: (2014)

Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic
por: Simard, Trevor, et al.
Publicado: (2021)

The balloon impasse sign in percutaneous transvenous mitral valvuloplasty
por: Simard, Trevor, et al.
Publicado: (2020)

Delays in ST-Elevation Myocardial Infarction Care During the COVID-19 Lockdown: An Observational Study
por: Clifford, Cole R., et al.
Publicado: (2020)

Impact of Center Experience on Patient Radiation Exposure During Transradial Coronary Angiography and Percutaneous Intervention: A Patient‐Level, International, Collaborative, Multi‐Center Analysis
por: Simard, Trevor, et al.
Publicado: (2016)

Safety of same-day discharge in patients with left main percutaneous intervention
por: Abdel-Razek, Omar, et al.
Publicado: (2022)

Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk
por: Simard, Trevor, et al.
Publicado: (2020)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Dipyridamole and vascular healing following stent implantation
por: Simard, Trevor, et al.
Publicado: (2023)

A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Li, Yachao, et al.
Publicado: (2023)

Contrast-free optical coherence tomography:Systematic evaluation of non-contrast media for intravascular assessment
por: Simard, Trevor, et al.
Publicado: (2020)

The Impact of De‐escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention
por: Qintar, Mohammed, et al.
Publicado: (2017)

Spontaneous coronary artery dissection in cardiac sarcoidosis
por: Kandolin, Riina, et al.
Publicado: (2019)

De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review
por: Han, Ya-Ling
Publicado: (2019)

Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
por: Ki, You-Jeong, et al.
Publicado: (2021)

Editorial: The individualization of antiplatelet therapy in coronary artery disease: escalation or de-escalations
por: Lee, Sang Yeub, et al.
Publicado: (2023)

De-Escalation of P2Y(12) Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention
por: Kupka, Danny, et al.
Publicado: (2018)

Ventricular Rupture at the Site of a Septic Myocardial Abscess After Acute Myocardial Infarction
por: Barry, Quinton, et al.
Publicado: (2022)

Platelet Quiescence in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Bypass Graft Surgery
por: Sarathy, Kiran, et al.
Publicado: (2021)

Cutting-Edge Coronary Imaging Guiding CABG
por: Shahinian, Jasmin H., et al.
Publicado: (2021)

Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial
por: Marbach, Jeffrey A., et al.
Publicado: (2022)

A novel echocardiographic hemodynamic index for predicting outcome of aortic stenosis patients following transcatheter aortic valve replacement
por: Yousef, Altayyeb, et al.
Publicado: (2018)

Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review
por: Farag, Mohamed, et al.
Publicado: (2022)

De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
por: Claassens, Daniel MF, et al.
Publicado: (2020)

Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality
por: Simard, Trevor, et al.
Publicado: (2017)

The Role of Coronary Physiology in Contemporary Percutaneous Coronary Interventions
por: Marin, Federico, et al.
Publicado: (2022)

Left Main Coronary Artery Percutaneous Coronary Intervention
por: Ferrante, Arnaud, et al.
Publicado: (2022)

Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
por: Gragnano, Felice, et al.
Publicado: (2022)

Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial
por: Koltowski, Lukasz, et al.
Publicado: (2019)

What should be the role of fractional flow reserve measurement in patients undergoing coronary artery bypass grafting?
por: Glineur, David, et al.
Publicado: (2020)

Erratum: Correction of Text in the Article “Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI”
por: Ki, You-Jeong, et al.
Publicado: (2022)

Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Zhao, Zhigang, et al.
Publicado: (2023)

Macromolecular Approaches to Prevent Thrombosis and Intimal Hyperplasia Following Percutaneous Coronary Intervention
por: Scott, Rebecca A., et al.
Publicado: (2014)

Bivalirudin in percutaneous coronary intervention
por: Lehman, Sam J, et al.
Publicado: (2006)

Percutaneous Coronary Intervention in the Elderly
por: Walsh, Simon J, et al.
Publicado: (2007)

Percutaneous Coronary Interventions in Women
por: Joodi, Golsa, et al.
Publicado: (2023)

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
por: Pham, Phuong-Anh, et al.
Publicado: (2011)

Hybrid coronary revascularization vs. percutaneous coronary interventions for multivessel coronary artery disease
por: Hannan, Edward L., et al.
Publicado: (2021)

Observational Cross-Sectional Study of Inflammatory Markers After Transient Ischemic Attacks, Acute Coronary Syndromes, and Vascular Stroke Events
por: Boczar, Kevin E., et al.
Publicado: (2020)

Successful Percutaneous Coronary Intervention for Atherosclerotic Coronary Lesion with Anomalous Origin of the Right Coronary Artery
por: Matsuda, Junji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_11c7m3ki8oevu4jij60o7s3rkp